Abstract
Background: Acute variceal bleeding (AVB) is a severe complication in cirrhotic patients. The optimal timing for endoscopic treatment remains uncertain.
Methods: A systematic search of PubMed, Embase, and the Cochrane Library was conducted. Outcomes included mortality, rebleeding rate, number of red blood cells (RBC) transfused, length of hospitalization, and other clinical endpoints. Study quality was assessed using the Newcastle–Ottawa Scale (NOS). Meta-analysis was performed using RevMan 5.4.1 (Cochrane, Oxford, United Kingdom) and Stata 18.0 (StataCorp LLC, College Station, United States), with subgroup, sensitivity, and publication bias analyses.
Results: No significant differences were observed between early and delayed endoscopy groups for the outcomes. However, in-hospital mortality was higher in the early endoscopy group (odds ratio (OR) = 1.55, 95% CI: 0.92-2.61, P = .10) and reached significance in sensi tivity analysis (OR = 1.76, 95% CI: 1.02-3.04, P = .04). Additionally, the early group tended to reduce the 6-week bleeding rate (OR = 0.78; 95% CI: 0.49-1.33; P = .4) and reached significance in sensitivity analysis (OR = 0.63, 95% CI: 0.43-0.92, P = .02). Moreover, the early group tended to require fewer RBC transfusions (mean difference (MD) = −0.62, 95% CI: −1.33 to 0.09, P = .09), confirmed in subgroup analysis (MD = −1.32, 95% CI: −2.41 to −0.24, P = .02).
Conclusion: No significant differences were found between groups for outcomes. However, subgroup or sensitivity analysis revealed that early endoscopy may increase in-hospital mortality, while reducing 6-week rebleeding and RBC transfusion. Further randomized trials are needed to confirm these findings.
Cite this article as: Jiang Y, Lu Y, Wang Y. Optimal timing of endoscopic intervention for acute variceal bleeding in cirrhotic patients: A systematic review and meta-analysis. Turk J Gastroenterol. 2026;37(3):281-291.
Most read articles by the same author(s)
- Guozhong Zhang, Xin Liu, Ying Wang, Kang Lu, Yang Wang, Serum GPC3 and AKR1B10 as Diagnostic Biomarkers for Hepatitis E Virus–Associated Acute Liver Failure , Turkish Journal of Gastroenterology: Vol. 37 No. 9 (2026): Turkish Journal of Gastroenterology
- Zhao Li, Jie Gao, ShengMin Zheng, Yang Wang, Xiao Xiang, Qian Cheng, Jiye Zhu, Therapeutic Efficacy of Sorafenib in Patients with Hepatocellular Carcinoma Recurrence After Liver Transplantation: A Systematic Review and Meta-Analysis , Turkish Journal of Gastroenterology: Vol. 32 No. 1 (2021): Turkish Journal of Gastroenterology
- Qiang Zeng, Jinglin Cao, Yishan Niu, Xin Zhao, Yang Wang, Wenpeng Liu, Baowang Liu, Yajie Chen, Yize Fan, Jian Dou, Identification of Recurrence-Related mRNAs and Noncoding RNAs in Hepatocellular Carcinoma Following Liver Transplantation , Turkish Journal of Gastroenterology: Vol. 34 No. 4 (2023): Turkish Journal of Gastroenterology

This work is licensed under a Creative Commons Attribution 4.0 International License.